CDC vaccine committee to discuss COVID-19 booster doses for immunocompromised people this week

The Centers for Disease Control and Prevention's influential vaccine advisory committee plans to meet Thursday to discuss the new safety warning for Johnson & Johnson's /zigman2/quotes/201724570/composite JNJ -1.85% COVID-19 vaccine and whether immunocompromised people will need a booster dose of a COVID-19 shot. The CDC's Advisory Committee on Immunization Practices has met several times during the pandemic to discuss COVID-19 vaccines. The meeting will be webcast.

/zigman2/quotes/201724570/composite

Add to watchlist JNJ

Johnson & Johnson

US : U.S.: NYSE

$ 151.05

-2.84 -1.85%

Volume: 7.94M

March 22, 2023 4:00p

P/E Ratio

22.41

Dividend Yield

2.99%

Market Cap

$400.77 billion

Rev. per Employee

$622,233